Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies

Abstract

Tofacitinib provides a treatment option for patients with active PsA, including the burdensome dermatologic symptoms of PsA.